REQUEST A DEMO
Total
USD $0.00
Search more companies

Tasly Pharmaceutical Group Co.,Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Tasly Pharmaceutical Group Co.,Ltd. Profile Updated: November 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

The Company is a limited-liability corporation reorganizedon the basis of " Tianjin Tasly United Pharmaceutical Co.",which was established in May 6 , 1994 and renamed as "Tianjin Tasly Pharmaceutical Co.,Ltd." on April 27, 2000.TheCompany's A shares was listed on Shanghai Stock Exchangeon August 23, 2002. It is a high-tech enterprise supported by Tianjin Government and engaged in scientific research, cultivation, extraction and sales of modern Chinese drug, chemical medicine and other productions. The company has successfully developed large automation pills production lines with the international advanced level. The leading product, compound danshen dripping pills, entranced the medicine market of Korea, Vietnam and other countries and regions as a drug.

Headquarters
No. 2, Pujihe East Road, Beichen District, Tianjin (Tasly Modern Chinese Medicine City)
Tianjin; Tianjin; Postal Code: 300410

Contact Details: Purchase the Tasly Pharmaceutical Group Co.,Ltd. report to view the information.

Website: http://www.taslypharma.com

Basic Information
Total Employees:
Purchase the Tasly Pharmaceutical Group Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Tasly Pharmaceutical Group Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Tasly Pharmaceutical Group Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Tasly Pharmaceutical Group Co.,Ltd. report to view the information.
Incorporation Date:
April 30, 1998
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
45.75%
Purchase this report to view the information.
2.69%
Purchase this report to view the information.
1.95%
Purchase this report to view the information.
1.05%
Purchase this report to view the information.
0.9%
Subsidiaries
Beijing Bozhi Technology Development Co., Ltd.
Beijing Rencheng Neuro-Oncology Biotechnology Engineering Research Center Co., Ltd.
Hefei Licheng Pharmaceutical Co., Ltd
Company Performance
Financial values in the chart are available after Tasly Pharmaceutical Group Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-1.66%
Total operating revenue
-3.21%
Operating profit (EBIT)
-17.12%
Net Profit (Loss) for the Period
-17.21%
Total assets
-4.76%
Total equity
2.33%
Operating Profit Margin (ROS)
-2.88%
Net Profit Margin
-2.41%
Return on Equity (ROE)
-1.5%
Debt to Equity Ratio
-13.52%
Quick Ratio
-0.39%
Cash Ratio
-0.36%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?